Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-08-05
2000-08-22
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514267, 514259, 514254, 514241, 5142305, 5142298, 5142342, 5142325, 5142285, 5142268, 5142225, 514212, 514210, 544254, 544 55, 544 56, 544 8, 544118, 544 82, 544180, 544264, 544284, 544353, 544102, 544262, 540600, C07D48704, A61K 31519
Patent
active
061073016
ABSTRACT:
The present invention provides novel compounds, compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppression, Alzheimer's disease, gastrointestinal diseases, anorexia nervosa, drug and alcohol withdrawal symptoms, drug addiction, inflammatory disorders, or fertility problems. The novel compounds provided by this invention are those of formula: ##STR1## wherein R.sup.1, R.sup.3, R.sup.4, R.sup.5, Z, Y, V, X, X', J, K, L, and M are as defined herein.
REFERENCES:
patent: 3669936 (1972-06-01), Regenass et al.
patent: 4229453 (1980-10-01), Roth et al.
patent: 4783459 (1988-11-01), Buhmann et al.
patent: 4788195 (1988-11-01), Torley et al.
patent: 4876252 (1989-10-01), Torley et al.
patent: 4992438 (1991-02-01), Ito et al.
patent: 5063245 (1991-11-01), Abreau et al.
patent: 5516775 (1996-05-01), Zimmerman et al.
patent: 5612340 (1997-03-01), Zimmerman
Dunn and Berridge, Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?, Brain Research Reviews, 15, 71-100, 1990.
R. Chambers et al., Polyhalogenoheterocyclic compounds Part 40. Tertiary Aromatic Amines as Carbon Nucleophiles, Tetrahedron, 48, 7939-7950, 1992.
R.C. Young et al, Purine Derivatives as Competitive Inhibitors of Human Erythrocyte Membrane Phosphatidylinositol 4-Kinase, Journal of Medicinal Chemistry, 33, 2073-2080, 1990.
S.V. Eswaran and S.K. Sajadian, Synthesis of Novel 9-Aryl-2,8-Dimethyl-9H-Purin-6-Amines Based on Sterically Hindered o-Bromoanilines, Organic. Prep. Proc. Int., 24(1), 71-73, 1992.
Aldrich Paul Edward
Arvanitis Argyrios Georgios
Bakthavatchalam Rajagopal
Beck James Peter
Cheeseman Robert Scott
Browder Monte R.
DuPont Pharmaceuticals Company
Ford John M.
Rubin Kenneth B.
LandOfFree
1N-alkyl-N-arylpyrimidinamines and derivatives thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1N-alkyl-N-arylpyrimidinamines and derivatives thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1N-alkyl-N-arylpyrimidinamines and derivatives thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-581390